Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL597792 | 0.98 | TSHR (0.31) | TSHR | |
| Iodide SCHEMBL1458237 | 0.96 | TSHR (0.30) | TSHR | |
| Hydrochloric Acid SCHEMBL366958 | 0.96 | TSHR (0.30) | TSHR | |
| SCHEMBL505985 | 0.90 | — | — | |
| SCHEMBL505454 | 0.90 | — | — | |
| Bromide SCHEMBL16163172 | 0.88 | DNM1 (0.31) | — | |
| Thiocyanic Acid SCHEMBL14483394 | 0.87 | — | — | |
| SCHEMBL1895593 | 0.86 | ALDH1A1 (0.30) | — | |
| Bromide SCHEMBL556685 | 0.85 | LMNA (0.35) | TSHR | |
| Bromide SCHEMBL28428048 | 0.85 | LMNA (0.35) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120136189-A1 | BUFFERED IONIC LIQUIDS FOR OLEFIN DIMERIZATION | CONOCOPHILLIPS COMPANY - IP SERVICES GROUP (US) | 2012-05-31 | — | — | US | claimed |
| US-20110185788-A1 | IONIC LIQUIDS AS SOLVENTS IN HEADSPACE GAS CHROMATOGRAPHY | KOCH PETER | 2011-08-04 | — | — | US | claimed |
| US-20100239524-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | NOVARTIS AG (CH) | 2010-09-23 | — | — | US | claimed |
| US-7569149-B2 | Ionic liquids as solvents in headspace gas chromatography | NOVARTIS AG (CH) | 2009-08-04 | — | — | US | claimed |
| US-20050205493-A1 | Ionic liquids as solvents in headspace gas chromatography | NOVARTIS AG (CH) | 2005-09-22 | — | — | US | claimed |
| US-5994602-A | IN THE PRESENCE OF A HYDROCARBYL ALUMINUM OR GALLIUM HALIDE AND A HYDROCARBYL-SUBSTITUTED IMIDAZOLIUM OR PYRIDINIUM HALIDE | BP CHEMICALS LIMITED (GB) | 1999-11-30 | — | — | US | claimed |
| WO-1998047616-A1 | CATALYST COMPRISING A BUFFERED IONIC LIQUID AND HYDROCARBON CONVERSION PROCESS, E.G. OLIGOMERISATION | BP CHEMICALS LIMITED (GB) | 1998-10-29 | — | — | WO | claimed |
| EP-0693045-B1 | ALKYLATION PROCESS | BP CHEM INT LTD (GB) | 1997-10-22 | — | — | EP | claimed |
| EP-0693045-A1 | ALKYLATION PROCESS | BP CHEM INT LTD (GB) | 1996-01-24 | — | — | EP | claimed |
| WO-1995021806-A1 | ALKYLATION PROCESS | BP CHEMICALS LIMITED (GB) | 1995-08-17 | — | — | WO | claimed |
| WO-1995021872-A1 | IONIC LIQUIDS | BP CHEMICALS LIMITED (GB) | 1995-08-17 | — | — | WO | claimed |
| EP-2593403-B1 | METHOD FOR PRODUCING A GEL FILM AND FILTRATION MEMBRANE PREPARED WITH THIS METHOD | UNIV MONASH (AU) | 2020-03-04 | — | — | EP | disclosed |
| EP-2435017-B1 | BENZYLIDENE MALONATES | BASF SE (DE) | 2019-10-23 | — | — | EP | disclosed |
| US-10297396-B2 | Graphene-based films | MONASH UNIVERSITY (AU) | 2019-05-21 | — | — | US | disclosed |
| EP-2451427-B1 | UV FILTER COMBINATIONS COMPRISING BENZYLIDENE MALONATES | BASF SE (DE) | 2018-04-25 | — | — | EP | disclosed |
| WO-1998047616-A1 | CATALYST COMPRISING A BUFFERED IONIC LIQUID AND HYDROCARBON CONVERSION PROCESS, E.G. OLIGOMERISATION | BP CHEMICALS LIMITED (GB) | 1998-10-29 | — | — | WO | disclosed |
| EP-0693045-B1 | ALKYLATION PROCESS | BP CHEM INT LTD (GB) | 1997-10-22 | — | — | EP | disclosed |
| EP-0693045-A1 | ALKYLATION PROCESS | BP CHEM INT LTD (GB) | 1996-01-24 | — | — | EP | disclosed |
| WO-1995021806-A1 | ALKYLATION PROCESS | BP CHEMICALS LIMITED (GB) | 1995-08-17 | — | — | WO | disclosed |
| WO-1995021872-A1 | IONIC LIQUIDS | BP CHEMICALS LIMITED (GB) | 1995-08-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239524-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | FIBP, MIF, CHMP4B | TSHR 3760/4885 |
| US-20120136189-A1 | BUFFERED IONIC LIQUIDS FOR OLEFIN DIMERIZATION | OSBPL8, OSBP, OSBP2 | TSHR 2589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.